Raja (Eladnani) Prince/LinkedIn
Dec 4, 2025, 02:34
Raja Prince and Team: Protein S as a Therapeutic Target
Raja Prince, Founder and BOD of BLEEDnFIRE Therapeutics, posted on LinkedIn:
”I’m delighted to share our newly published review in Journal of Thrombosis and Haemostasis (JTH).
In this article, our team provides an updated and comprehensive overview of protein S as a therapeutic target, summarizing current knowledge, emerging therapeutic strategies, and key challenges in the field of hemostasis.
A big thank you to my two coauthors, Rim Diab and Anne Angelillo-Scherrer.”
Read the full article here.
Title: Protein S as a therapeutic target
Authors: Raja Prince Eladnani, Rim Diab, Anne Angelillo-Scherrer
Stay updated with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis